Clinical trial
Non-Interventional Collecting Evidences For ILD in Taiwan: Optimized Novel Therapy
NCT04614441 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-Interventional Collecting Evidences For ILD in Taiwan: Optimized Novel Therapy
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 21, 2021
- Completion date
- May 14, 2025
- Enrollment
- 214 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.